iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a significant decrease in short interest in May. As of May 29th, there was short interest totaling 568 shares, a decrease of 84.6% from the May 14th total of 3,688 shares. Based on an average daily volume of 4,094 shares, the short-interest ratio is presently 0.1 days. Approximately 0.2% of the company’s shares are sold short.

Institutional Trading of iShares Health Innovation Active ETF

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Price Performance

NYSEARCA:BMED remained flat at $28.66 during trading hours on Wednesday. The company’s stock had a trading volume of 1,239 shares, compared to its average volume of 4,114. The stock has a market cap of $10.32 million, a P/E ratio of 24.91 and a beta of 0.75. iShares Health Innovation Active ETF has a one year low of $24.20 and a one year high of $32.19. The stock has a fifty day simple moving average of $28.39 and a 200-day simple moving average of $29.70.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.